SABCS Session Provides Clinical Implications of New Data and Practical Takeaways
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
Experts reflected on how clinical decision-making for treating breast cancer may change in light of the latest results shared...
At the San Antonio Breast Cancer Symposium, experts discussed the implications of sexual health, supplements, exercise, and diet for...
A session on molecular degraders at SABCS 2024 highlighted an exciting new frontier for SERDs, PROTACs, LYTACs, and biparatopic...
Researchers at the 2024 San Antonio Breast Cancer Symposium discussed considerations for treating and managing of early-onset breast cancer.
Studies presented at the 2024 SABCS examined ways to predict responses to treatments for HR-positive, HER2-negative breast cancer.
Data from clinical trials presented at SABCS may help patients with DCIS make informed choices between different management...
The blog rounds up the 2023 SABCS, which had 10,874 in-person and virtual registrants and featured cutting-edge research, thoughtful...
Charles Swanton, MD, PhD, FAACR, spoke on the role chromosomal instability plays in breast cancer evolution.
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...